Congress turning its attention to the lack of accountability of the 340B drug prescription program

Congress is turning its attention toward hospital participating in the 340B drug prescription program following a series of studies that raised concern what they described as lack of accountability and oversight of the program intended to help hospitals give drug discounts to underserved patients. The Senate HELP Committee has expressed sympathy for the care 340B hospitals provide to the underserved, but said it may be necessary to require hospitals and clinics to report how they use savings from the program. Read article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.